Why the study?
What are the differing hemodynamic mechanisms of blood pressure reduction between tilisolol and doxazosin in outpatients with essential hypertension?
What are the differing hemodynamic mechanisms of blood pressure reduction between tilisolol and doxazosin in outpatients with essential hypertension?
Tilisolol lowers blood pressure primarily by reducing cardiac output without increasing peripheral resistance, whereas doxazosin lowers blood pressure by decreasing total peripheral resistance.
Answers are grounded in this paper and cite their sources.
Tilisolol and doxazosin lower BP via distinct hemodynamics; hypothesis-generating for mechanism-specific selection in hypertension.
To investigate the hemodynamic effects of tilisolol (N-696), a new β-blocking agent with vasodilating property, and doxazosin, a new α-blocking agent, cardiac performance by RI angiocardiography using 99mTc in vivo-labelled red cells was studied by introducing the drugs orally to 22 outpatients with essential hypertension.These two drugs reduced blood pressure significantly (P<0.005) with different changes in heart rate; tilisolol reduced heart rate, though doxazosin did not. Cardiac index decreased in the tilisolol-treated group (3.28±0.15to2.85±0.09l/min/m2, P<0.01), but the change was not significant in the doxazosin-treated group.Tilisolol and doxazosin induced no significant change in left ventricular ejection fraction . Total peripheral resistance index (TPRI) stayed at pretreatment level in the tilisolol-treated group (3, 161±194 to 3, 167±89 dyn·sec·cm-5·m2);however, TPRI decreased in the doxazosin-treated group (3, 072±166 to 2, 546±207dyn·sec·cm-5·m2, P<0.01).These two drugs did not induce any significant change in circulating blood volume evaluated by 131I-labelled human serum albumin.Tilisolol a non-selective β-blocking agent with vasodilating property, reduced cardiac output without any significant change in TPRI . As tilisolol was reported to have no in trinsic sympathomimetic activity (ISA) on vascular β2-receptors in animal experiments, its direct vasodilating property was assumed to counteract and minimize an increase in TPRI induced by vascular β2-receptor blocking action and reduced cardiac pump function .Hemody namic effiects induced by doxazosin may be explained mainly by its vascular α1-receptor blockade with a resultant decrease in TPRI .
No takes yet. Share an insight, caveat, or question.
Tsukiyama et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: